ESR and CRP as inflammation biomarkers have been widely utilized for evaluating disease activity and medicine efficacy41, while ASDAS-CRP and ASDAS-ESR are spondylitis-specific assessments42. This evidence concerns the gene ESR1 and spondylitis.